Clinical trial
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
NCT06577987
Study timeline
Study start (actual)2024-08-14Date precision: day
Registry last updated2026-08-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Solid Tumorunresolved
Metastatic Solid Tumorunresolved
Refractory Solid Tumorunresolved
Cancerunresolved
Lung Cancerunresolved
Triple Negative Breast Cancerunresolved
Breast Neoplasmsunresolved
Neuroendocrine Tumorsunresolved
Neuroendocrine Carcinomaunresolved
RB1 Gene Mutationunresolved
Interventions
Sponsors & collaborators
Circle Pharmalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06577987 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.